A male infant with a severe neutrophil motility disorder and poorly polymerizable actin in PMN extracts was reported over a decade ago to have neutrophil actin dysfunction (NAD) (1974. N. Engl. J. Med. 291:1093-1099). Polymerized actin (F-actin) content of fixed and permeabilized intact neutrophils from the father, mother, and sister of the NAD index case have been measured using nitrobenzoxadiazole-phallacidin, a fluorescent compound which binds specifically to actin filaments.
Introduction
In 1974, Boxer et al. (1) published a case report describing a male infant who suffered from recurrent bacterial infections. The infant's PMNs were severely defective in their ability to migrate and to ingest particles. Whereas most of the actin in 0.6 M KCI extracts prepared from normal PMNs assembled into sedimentable filaments, only a small fraction of the pa-tient's PMN actin polymerized. This finding raised the possibility that a disorder of PMN actin function might be the cause of this profound defect in granulocyte motility.
Here we have documented partial impairment of actin assembly in PMN extracts of the parents of this infant. We have also investigated actin assembly in intact PMN and found that resting and maximal actin filament concentrations after chemotactic stimulation were lower than normal in PMNs from three family members. These findings confirm a true defect in neutrophil actin assembly and indicate that neutrophil actin dysfunction (NAD)' is a recessively inherited disease.
Methods

Patients
Family members ofthe index case ofNAD included the father (age 42), the mother (age 41), and two sisters (ages 18 and 15). Except for the father, who has insulin-dependent diabetes mellitus, all members of the family were healthy. None ofthe index case's relatives had a history of recurrent infections. All family members had normal peripheral granulocyte counts. The mother's and father's PMNs demonstrated normal phagocytosis (1) . The younger sister on one occasion developed nausea and light-headedness during venipuncture; therefore, her neutrophils were not used for any of the present studies.
Isolation ofhuman granulocytes
These studies were reviewed and approved by the appropriate review boards of the institutions participating. Whole blood samples were drawn from patients and healthy controls. 20 cm3 of each blood sample was anticoagulated with citric acid/trisodium citrate/dextrose 5 cm3 of solution containing 0.8 g/dl citrate, 2.2 g/dl Na citrate, and 2.45 g/dl glucose. Samples were then subjected to dextran sedimentation for 60 min by addition of 7 cm3 of 2 g/dl T-500 dextran (Pharmacia Fine Chemicals, Piscataway, NJ) in a 0. 15 -M NaCl solution. The resulting supernatant solution was diluted with 0.15 M saline and centrifuged at 250 g for 10 min. The cell pellet was then washed twice in 30 vol of 0.15 M NaCI solution and centrifuged at 250 g for 10 min. This method yielded white blood cell preparations containing 80-85% PMNs. The remaining cells were lymphocytes and monocytes. In some preparations PMNs were purified from citrate anticoagulated whole blood using Ficoll sodium diatrizoate solution according to the method of Boyum (2) . This method yielded 95-98% PMNs, the other cells being monocytes and lymphocytes.
For FACS analysis of nitrobenzoxadiazole (NBD)-phallacidinstained PMNs, 6 ml of venous blood was drawn into syringes containing 0.4 ml of 10 g/dl EDTA in distilled water. Red blood cells were lysed by the addition of 34 cm3 distilled water, followed immediately by the addition of 4.4 ml 3.1-M NaCI. The samples were then centrifuged at 400 g for 5 min. Cells were resuspended in modified HBSS (138 mM NaCl, 6 mM KCl, 1.2 mM MgSO4, 5 mM NaHCO3, 0.64 mM Na2HPO4 [pH 7.4] , 0.66 mM KH2PO4, 5.6 mM glucose, and 20 mM Hepes) and centrifuged at 400 g for 5 min. This procedure was repeated once and cells resuspended in modified HBSS to achieve a final concentration of 1.5 X 106 cells/ml. On average these preparations contained a mixture of 83±1.4% (mean±SEM) PMNs, 11±1.7% lymphocytes, and 5.1±0.8% monocytes as determined by Wright stain (nine determinations). Platelets were not seen on any of these smears. This method was developed to minimize handling of cells and reduce the likelihood of inadvertent PMN activation before stimulation with the agonist (3). Cells were maintained at room temperature, and all experiments were performed within 3 h of venipuncture.
For the Triton-insoluble cytoskeleton assay PMNs were also suspended in modified HBSS. CaC12 (final concentration of 1 mM) was added to cell suspensions 10 min before cell stimulation unless otherwise noted in the text.
Preparation ofgranulocyte extracts
Granulocytes packed by centrifugation were suspended in an equal volume of 0.15 M NaCI to which was added 15 vol deionized water. They were then immediately centrifuged for 10 min at 250g. This step lysed most erythrocytes. The granulocytes were next suspended in homogenization buffer containing 0.34 sucrose, 5 mM DTT, 5 mM ATP, 5 mM EGTA, and 20 mM imidazole-HCI, pH 7.5. The cells were then broken at ice bath temperature by 60-120 strokes with a tight-fitting pestle in a glass Dounce homogenizer (Kontes Co., Vineland, NJ). This procedure ruptured > 90% of all cells as monitored by phase contrast microscopy. The resulting homogenates were centrifuged at 12,000 g for 30 min, yielding a clear supernatant, designated granulocyte extract. This supernatant solution had a pH of 6.8-7.1, which was adjusted to 7.5 by the addition of a few drops of 0.1 M sodium hydroxide. The final protein concentration of the granulocyte extracts varied between 3 and 8 mg/ml. In some experiments cells were treated with 5 mM diisopropylfluorophosphate (DFP) as described by Amrein and Stossel (4) before homogenization. For studies of actin polymerization inhibitory activity (see Table II ), granulocyte extracts were depleted of native actin by the addition of a final concentration of 0.6 M KCI and then were incubated for 2 h at 25°C and centrifuged at 100,000 g for 2 h. The resulting supernatant was dialyzed against buffer B, containing 0.5 mM ATP, 1 mM DTT, I mM EGTA, and 10 mM imidazole-HCI, pH 7.5, before the addition of purified rabbit skeletal muscle actin.
Purification ofgranulocyte actin
Granulocyte extracts were diluted 1:1 with a solution containing 0.75 M guanidine hydrochloride, 30% glycerol, 1 mM CaCI2, and 0.5 M sodium acetate buffer, pH 8 (buffer A). The extracts were then passed through a 1 X 12-cm DNase-Sepharose column prepared as described by Lazarides and Lindberg (5). The column was first eluted with three column volumes of 0.75 M guanidine hydrochloride in buffer A. This was followed by elution with 3 M guanidine hydrochloride in buffer A. 6-ml fractions were collected, dialyzed against 1,000 vol cold deionized water for 18-24 h, and Iyophilized. All procedures were performed at 4°C. The purity of the actin samples was assessed by SDS-PAGE.
Peptide mapping ofgranulocyte actin 300-700 Mg DNase I affinity-purified PMN actin was oxidized with performic acid and digested with a 1:50 wt/wt ratio of trypsin to actin for 2 h at 370C (6) (L-l-tosylamido-2-phenylethyl chormethyl ketonetreated trypsin; Worthington Biochemical Corp., Freehold, NJ). The Iyophilized digest was dissolved in 0.5 ml of 10% acetonitrile/0.1% trifluoroacetic acid and applied to a 14 X 300-mm C-18 Bondapack steel column (Waters Associates, Milford, MA). The column was then eluted with a linear gradient of 10-50% acetonitrile over 60 min. The flow rate was 1 ml/min. Two-dimensional thin layer chromatography of purified PMN actin was performed exactly as described by Elder et al. (7) .
Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis was performed as described by O'Farrell (8) . Isoelectric focusing was performed using 9 M urea, 0.6% pH 3-10, and 1.4% pH 4-6 ampholines.
Measurement ofactin polymerization in granulocyte extracts Sedimentation assay. Granulocyte extracts were made 0.6 M with 3 M potassium chloride and incubated 2 h at 250C. Samples were then centrifuged at 160,000 g for 30 min in an air-driven centrifuge (Airfuge; Beckman Instruments, Inc., Palo Alto, CA). Under these conditions globular molecules with molecular weights . 600,000-700,000 would be expected to sediment. To determine the amount ofactin that had sedimented, protein concentrations ofthe starting solution and the supernatant after centrifugation were determined using the biuret method (9) . The fraction of total protein representing actin was determined by quantitative densitometry of Coomassie Blue-stained polyacrylamide gels after electrophoresis of the solutions in SDS.
Viscometry assay. Specific viscosities of purified actin subjected to polymerizing ionic conditions in granulocyte extracts were measured with semimicroviscometers (extra low charge, size 100; Cannon Instrument Co., State College, PA) as previously described (10) .
Measurement ofactin filament assembly in intact PMNs NBD-phallacidin assay. 0.5 ml of cell suspensions (0.75 X 101 cells/ sample) were incubated for 7 min at 250C. 0.5 ml of a 1 X 10-6 M FMLP solution or buffer was added to each sample. The reaction was stopped by addition of 0.1 ml of 37% formaldehyde. Cells were incubated in fixative for 15 min at 250C before staining for F-actin accordingto the method ofHoward and Oresajo (1 1). 50 Ml ofmodified HBSS containing 3.46 X 10-6 M NBD-phallacidin and 2.1 mg/ml lysophosphatidal choline were added to the fixed cell preparations, which were then mixed and incubated for 10 min at 370C and then centrifuged at 12,000 g for 1 min. Supernatants were removed and pellets suspended in 1.5 ml of modified HBSS.
Stained cells were analyzed as previously described (3). Briefly, the intracellular fluorescence was determined by a Spectrum III flow cytometer (Ortho Diagnostic Systems Inc., Westwood, MA) equipped with an argon laser (488 emission, 500 mW output). All intensities ofcellular fluorescence were recorded on the linear scale ranging from 0 to 255 channels. Intensity values were standardized daily using fluorescent polystyrene spheres. Fluorescent histograms plotting cell number (vertical axis) vs. fluorescence channel (horizontal axis) were recorded for each sample. In all instances the histograms yielded a normal distribution (the peak fluorescence channel corresponded to the mean fluorescence). An average of 5,000-10,000 PMNs per sample were analyzed. PMN F-actin content was expressed as mean fluorescence intensity. Gain settings were identical for patient and control PMNs. Unstimulated values were comparable when cells were incubated in modified HBSS or 0.01% DMSO (the highest concentrations used in our experiments) in modified HBSS.
Actin association with the Triton-insoluble cytoskeleton. A modification of the method described by White et al. (12) was used. Human PMNs were purified on Ficoll/Hypaque gradients as described above, suspended in modified HBSS, centrifuged at 400 g, and resuspended in the same buffer to achieve a final concentration of 1.5 X I07 cells/ml. 500 Al ofthe cell suspension was added to 55 Ml of a 5 X 10-6 M FMLP solution. The reaction was stopped by the addition of 65 Ml of a solution containing 10% Triton X-100, 0.075 mg/ml benzamidine, 0.04 mg/ml aprotinin, 0.01 mg/ml leupeptin, 1 Actin polymerization in granulocyte extracts. When extracts from normal granulocytes were made 0.6 M in KCI, a percentage of the extract actin sedimented when centrifuged at 160,000 g for 30 min. Since the cell concentration from which extracts were prepared varied considerably among experiments, there was also variation in the granulocyte extract total protein concentration; therefore, the relationship between the extract total actin concentration and actin sedimentability was determined in each experiment. The fraction of sedimented actin was proportional to the total extract actin concentration (Fig. 1) . Above a concentration of 2.5 MM, actin in control extract was detectably sedimentable. The slope of the line relating total concentration of actin to actin filament concentration (sedimented actin) was 0.83. Under these same conditions the viscosity ofthe extract as well as its flow birefringence have been shown to increase (10) . These findings are all consistent with the assembly of actin into linear filaments rather than nonspecific aggregation, and suggest that the increase in sedimentability of actin reflects actin polymerization. When KCI was added to granulocyte extracts of the parents of the patient described by Boxer et al. (1) , the concentration at which actin was detectably polymerized was 5.2 gM (twice the control value) and the slope of the line relating total actin to F-actin concentration was 0.44 (approximately one-half of control value) (Fig. 1) patients and controls (Fig. 3) . Actin filament assembly in intact PMNs was also assessed by measuring the concentration of actin associated with the Triton-insoluble cytoskeleton before and after stimulation with FMLP. As shown in Fig. 4 In addition to actin, the relative concentrations of nine other oligopeptide bands visualized on one-dimensional SDS-PAGE were quantitated in control Triton-insoluble PMN cytoskeletons and these values compared with PMN from NAD family members (Fig. 5) . Significantly higher concentrations of a 54,000-mol wt protein were found in the Triton-insoluble fractions of the mother's and older sister's PMNs (mother: mean 9.2% of the total protein, four determinations; sister: mean 5.4%, two determinations, vs. 3.9%±0.2 SEM, range 2.9-4.6% for control PMN, n = 9, P < 0.001 and P = 0.012, respectively). No differences in the concentrations of other cytoskeleton-associated proteins were observed. Neither treatment of PMN with DFP nor stimulation with FMLP significantly altered the concentrations ofthe 54,000-mol wt protein in the mother's or older sister's PMN Triton-insoluble fractions.
The lower than normal rise in F-actin content associated with FMLP stimulation of PMN from NAD family members did not appear to be caused by a decrease in functional FMLP receptors. FMLP receptor function was assessed using a degranulation assay (Table I) . The concentrations ofcompounds known to be released from primary (f-glucuronidase) and secondary (vitamin B12 binding protein) granules were measured after PMNs were exposed to increasing concentrations of the peptide (I0-9-I0-7 M) in buffer containing cytochalasin B.
Concentrations of f-glucuronidase and B12 released from the mother's and father's PMNs were similar to control. Compounds released from unstimulated PMNs were also similar in control and parents, suggesting that parental PMN granules were not abnormally fragile. Finally, in the absence of cytochalasin B, degranulation of parental PMNs after exposure to IO-' M FMLP did not differ from controls.
Preliminary investigations ofthe biochemical basis for defective PMN actin assembly. The formidable complexity of polymerization of pure actin compounded by the environment of cell extracts that contain proteins that can promote or inhibit actin assembly (15, 16) has made understanding normal PMN extract actin, much less an abnormal PMN actin function, difficult. Because our investigations are inconclusive, they will be only briefly summarized. We investigated the possibility of an abnormal actin-modulating protein that might prevent actin monomers or actin oligomers from combining to form filaments in affected cells. As shown in Table II , when granulocyte extract was prepared as described in Fig. 1 Figure 6 . Reverse phase HPLC profiles of oligopeptides derived from tryptic digestion of control and NAD PMN actin purified by DNase I affinity chromatography. Actin was purified from extracts of DFPtreated PMNs from a control and the father of the NAD index case. 300-700 ug of actin was oxidized with performic acid and then digested with trypsin as described in Methods. The digested actin was lyophilized, resuspended in 0.5 ml 10% acetonitrile/0.1% trifluoroacetic acid, and applied to a C-18 Bondapack column. The column was then eluted with a linear gradient of 10-50% acetonitrile over 60 min at flow rate of 1 ml/min. Absorbance was monitored at 206 nm. The only major difference between patient and control profiles was a prominent peak at 40 min. This fraction was resubjected to trypsin digestion and rechromatographed. The elution profile was identical to control actin, indicating that this peak represented undigested actin.
single peak that eluted at 40 min (Fig. 6) . Exposure of this peptide solution to further trypsin digestion demonstrated that this peak represented undigested actin. Two-dimensional tryptic peptide maps of similarly purified PMN actin from a control and the father also failed to demonstrate any significant differences in the peptide maps (data not shown).
Discussion
Boxer et al.'s original studies of an infant with a severe neutrophil motility disorder raised the exciting possibility that defective phagocytosis and chemotaxis in this patient's PMNs might be caused by abnormal neutrophil actin assembly (1) . NAD remains the only disease thought to be associated with a defect in actin function; therefore, this disorder is of considerable interest not only to neutrophil investigators but also to cell biologists and contractile protein biochemists. The original studies of actin assembly used extracts derived by homogenizing resting neutrophils. It has been suggested that these studies may not accurately reflect the true functional state of actin in intact PMNs. Homogenization may release multiple granule proteins including proteolytic enzymes that may result in damage to actin and actin-modulating proteins. The assay takes several hours to perform; during this time actin function may deteriorate. Finally, maximal stimulation of actin assembly in extracts requires the addition of an unphysiologic concentration of potassium chloride (0.6 M) (10) .
To more accurately assess PMN actin function, two assays that are capable of measuring actin filament assembly in intact cells before and after exposure to a physiologic stimulus were used: NBD-phallacidin and actin associated with the Tritoninsoluble cytoskeleton. These studies have demonstrated that both resting and maximal concentrations of actin filaments after chemotactic stimulation are lower than normal in PMNs from the father, mother, and older sister of the original NAD index case. In addition, using the original extract assay of 
